Immunotherapy for Advanced Melanoma
- 1 November 2008
- journal article
- review article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 128 (11), 2596-2605
- https://doi.org/10.1038/jid.2008.101
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signalingJournal of Clinical Investigation, 2007
- Enhanced Antitumor Activity of T Cells Engineered to Express T-Cell Receptors with a Second Disulfide BondCancer Research, 2007
- Extrathymic Generation of Tumor-Specific T Cells from Genetically Engineered Human Hematopoietic Stem Cells via Notch SignalingCancer Research, 2007
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastasesMolecular Cancer Therapeutics, 2006
- Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4Journal of Clinical Oncology, 2006
- Adoptive immunotherapy for cancer: building on successNature Reviews Immunology, 2006
- Successful treatment of malignant melanoma in situ with topical 5% imiquimod creamInternational Journal of Dermatology, 2005
- Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?Immunology Today, 1995
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985